Experiences with
Small cell lung cancer33,496 public posts
New approval for treatment of Small Cell Lung Cancer (SCLC)
Read the full FDA announcement here:https://go2.org/blog/fda-approves-imdelltra-tarlatamab-dlle-for-extensive-stage-small-cell-lung-cancer/
Share your experience of early-stage non-small cell lung cancer
Have you had surgery or radiotherapy for early-stage non-small cell lung cancer within the past year?
Did you have you cancer treatment in England?
Are you available to take part in a 1-hour interview online, by phone or in person?
Please join us next Tuesday, October 15th, for our Living Room discussion on Treating EGFR Mutated Non-Small Cell Lung Cancer
Join us for a conversation on how new targeted therapies and a greater understanding of tumor biology have advanced treatments for EGFR-mutated non-small cell lung cancer (NSCLC). First-generation targeted therapy drugs outperformed traditional chemotherapy, but new mutations led to resistance.
Want to take advantage of all our features? Just log in!
or
Estela's Story - Why Low-Dose Lung Cancer Screening Should Be Routine
In 2022, much to my shock, I was diagnosed with small cell lung cancer (SCLC). At the time, I had no idea what small cell lung cancer meant. Naively, I assumed that “small” meant insignificant. It was not insignificant.
Success in early stage sclc with imfinzi.
Thought this was as worth sharing here
https://www.cancer.gov/news-events/cancer-currents-blog/2024/small-cell-lung-cancer-imfinzi-increases-survival?cid=eb_govdel_cancerinfo
Some success in limited stage sclc.
https://www.cancer.gov/news-events/cancer-currents-blog/2024/small-cell-lung-cancer-imfinzi-increases-survival?cid=eb_govdel_cancerinfo
A Veteran’s Experience with Small Cell Lung Cancer (SCLC)
Read about Jim's story here: https://go2.org/blog/a-veterans-story-with-small-cell-lung-cancer-sclc/
FDA Approves Tepmetko (tepotinib) for People with Metastatic Non-Small Cell Lung Cancer with MET-Exon 14 Mutation
Food and Drug Administration (FDA) granted traditional approval of Tepmetko (tepotinib) for people living with metastatic non-small cell lung cancer (NSCLC) with a MET-Exon 14 mutation.
FDA Approves Augtyro (repotrectinib) for Adults and Children with NTRK-Positive Solid Tumors
Food and Drug Administration (FDA) granted accelerated approval of Augtyro (repotrectinib) for adults and children aged 12 years and older with NTRK-positive solid tumors, including both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
FDA approval Alecensa (alectinib) following surgery for people with early stage ALK positive NSCLC
Here is the link to read more: https://go2.org/blog/fda-approves-alecensa-alectinib-following-tumor-resection-for-people-with-early-stage-alk-positive-non-small-cell-lung-cancer/
Please join us next Tuesday, March 19th for our Small Cell Lung Cancer Treatment Landscape Living Room
Speaking on Small Cell Lung Cancer Treatment Landscape-Hope is on the Horizon.
He will be sharing all the new research, advancements and studies happening in Small Cell with all the new therapies hope IS on the horizon.
You don't want to miss this!
The new GO2 handbook is here! Navigating Small Cell Lung Cancer – 360° of HOPE
Navigating Cell Lung Cancer – 360° of HOPE is a free comprehensive handbook with detailed small cell lung cancer information ranging from diagnosis to treatment, managing side effects, addressing quality of life, and so much more.